Repligen | RGEN - Ebitda





Ebitda Veränderung Datum
Agilent USD 456M 84M 2025-12
Align Technology USD 260.87M 77.03M 2025-12
Bio Techne USD 116.71M 13.29M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Bruker USD 110M 101.6M 2026-03
Charles River Laboratories USD 229.8M 28.26M 2026-03
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 129M 6M 2026-03
General Electric Aerospace USD 2.84B 568M 2026-03
Henry Schein USD 289M 2M 2026-03
Illumina USD 469M 137M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
Mettler Toledo International USD 278.99M 100.24M 2026-03
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Pfizer USD 5.99B 5.23B 2026-03
Repligen USD 40.01M 469K 2026-03
Revvity USD 272.91M 24M 2026-03
Standard Biotools USD -15.81M 734K 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Waters USD 380.97M 85.83M 2025-12
West Pharmaceutical Services USD 226.2M 7.7M 2026-03